ClinVar Miner

Submissions for variant NM_000080.4(CHRNE):c.1434C>A (p.Tyr478Ter)

gnomAD frequency: 0.00002  dbSNP: rs763943642
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000760410 SCV000890287 likely pathogenic not provided 2018-08-01 criteria provided, single submitter clinical testing The Y478X variant in the CHRNE gene has been reported previously (as Y458X, due to alternate nomenclature) in the heterozygous state in two individuals from one family with AChR deficiency syndrome (Ealing et al., 2002). Functional assessment of the Y478X variant displayed reduction of surface localization of AChR compared to wild type (Ealing et al., 2002). This variant is predicted to cause loss of normal protein function through protein truncation. The Y478X variant is not observed in large population cohorts (Lek et al., 2016). We interpret Y478X as a likely pathogenic variant.
Invitae RCV002533835 SCV003443726 uncertain significance Congenital myasthenic syndrome 4A 2024-01-04 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Tyr478*) in the CHRNE gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 16 amino acid(s) of the CHRNE protein. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with CHRNE-related conditions and/or clinical features of autosomal recessive congenital myasthenic syndrome (PMID: 12417530; Invitae). This variant is also known as p.Tyr458*. ClinVar contains an entry for this variant (Variation ID: 620130). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this premature translational stop signal affects CHRNE function (PMID: 12417530). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.